GLP and QA for Histology and Pathology of Drug Safety...
Transcript of GLP and QA for Histology and Pathology of Drug Safety...
Quality and GLP
for Histology and Pathology of
Drug Safety Studies
Roger Alison BVSc MRCVS DiplECVP
Consultant Toxicological Pathologist
www.rogeralison.com
What is Quality Histology?
It depends upon the purpose
- Answer research questions
- Diagnosis
- Screening
- Support regulatory submissions
www.rogeralison.com
Quality Regulatory Histology
Fitness for the purpose
- Acceptability
- Reliability
- Consistency
- Reproducibility
- Retrievability
www.rogeralison.com
Quality Systems
- Good Laboratory Practice (GLP)
- Others:
- Good Clinical Practice (GCP)
- Good Manufacturing Practice (GMP)
- ISO 9000
www.rogeralison.com
GLP
Definition
- GLP is a quality system concerned with
the organisational process and the
conditions under which non-clinical
health and environmental safety studies
are planned, performed, monitored,
recorded, reported and archived.
www.rogeralison.com
Purpose of GLP
- Ensure consistent, reliable standards of
safety testing world-wide
- Promote the quality and integrity of test
data
- Improve human and environmental
safety
www.rogeralison.com
Origin of GLP
Introduced because of fraud or poor quality
work in US in 1970s:
- Dead animals “reappeared”
- Tumours “disappeared”
- Inadequate mixing of dose in diets
- Inadequate/insufficient documentation
- Replacement of animals
www.rogeralison.com
GLP is necessary...
Ethically: prevent fraud, public risk,
unnecessary use of animals
Economically: avoid waste of time and money
Scientifically: avoid acceptance of false
results
Regulatorily: ensure confidence in regulatory
decisions
www.rogeralison.com
GLP is required for...
All studies to assess the safety of:
- Drugs and medical devices
- Pesticides
- Chemicals
- Biologicals
www.rogeralison.com
Personnel
Sponsor
- Study Monitor
Test Facility/Test Site(s)
- Management
- Study Director/Principal Investigator(s)
- Study Personnel
- Lead Quality Assurance (facility)
- Test Site Quality Assurance Unit(s)
www.rogeralison.com
Sponsor
Commissions and submits GLP work
Responsible for:
- Ensuring laboratory is GLP compliant
- Test material information
- Approval of protocol
- Archiving – if contract laboratory or test
facility goes out of business
www.rogeralison.com
Management
Ensure GLP complied with:
- Designate a Study Director
- Ensure staff are trained and experienced
- Ensure adequate resources are available
- Approve SOPs
- Ensure QA programme exists (and
reports to management)
www.rogeralison.com
Study Director
The single point of study control
Takes responsibility for the overall conduct of
the study and its final report
www.rogeralison.com
Study Director ensures...
- GLP is followed
- Adequate trained personnel and suitable
equipment
- Personnel approve the protocol
- Protocol, amendments and SOPs are
available to study personnel
- Procedures specified in the protocol are
followed
www.rogeralison.com
Study Director ensures...
- Unforseen events are noted and assessed
- Raw data fully documented
- Approves and signs the report
- Archives study material promptly on
completion of the study
www.rogeralison.com
Principal Investigator
At sites separated from the SD, the PI
oversees critical phases of the study
- Drafts relevant protocol sections
- Ensures work is conducted to GLP and
in accordance with protocol and SOPs
- Prepares contributing report
- Ensures raw data is archived
www.rogeralison.com
Study Personnel
- Know Principles of GLP applicable to
their involvement in the study
- Ensure their training record is up to date
- Follow protocols, SOPs
- Report problems, mistakes, unexpected
events, and involved in corrective action
- Record data promptly, accurately,
completely
www.rogeralison.com
Quality Assurance
Independent of study conduct
- inspect study at intervals
- protocol
- in-life data, procedures
- report
- facilities
- Report to management and SD
www.rogeralison.com
Protocols and SOPs
Specify how a study is to be conducted:
- What is going to be done
- Who will do it
- When will it be done
- What data will be recorded
www.rogeralison.com
Protocols and SOPs
Protocols (study plans)
- Study specific instructions, often linking
SOPs and providing timings
SOPs:
- Standard: routine
- Operating: working
- Procedures: methods
www.rogeralison.com
Protocol
GLP requires:
- A written plan, before start of the study
- Verified for compliance by QA
- Approved by test facility management
(and usually by sponsor)
- Approved by dated signature of Study
Director
www.rogeralison.com
Protocol
Informs:
- Study staff, support staff
- Management
- Subcontractors, Principal Investigators
Confirms responsibilities (by signature):
- Study Director
- Management
- Principal Investigators
www.rogeralison.com
Protocol
Information included:
- When animals to be killed
- Tissues to be taken at necropsy
- Tissues to be processed
- Slides made: group, numbers, staining
- Slides examined (control, high dose?)
- Special techniques
- Staff responsible
www.rogeralison.com
Protocol Deviations
Protocol Amendments: (study plans)
- Planned changes to the original study
design
Protocol Deviations:
- Omissions or deviations (“errors”)
- Should be recorded separately
- Not as retrospective amendments
- Assessed for significance
www.rogeralison.com
SOPs
Histology SOPs:
- Tissue trimming
- Sectioning
- Staining, including special stains
- Equipment maintenance
- Records to be kept
- Slide shipping
- Chain of custody
www.rogeralison.com
SOPs
Guides for organ sampling and trimming in
rats and mice:
http://reni.item.fraunhofer.de/reni/trimming/
www.rogeralison.com
SOPs
Benefits:
- Consistency (between staff, over time)
- Training
- Reconstruction of methods used in past
- Avoids repetitive documentation of
procedures
- Problems only have to be solved once
www.rogeralison.com
Data and Documentation
When the study is completed, the data,
documentation and samples must
completely support what was done
It must be possible for a third party to
reconstruct the study from what remains
www.rogeralison.com
Data and Documentation
Identifies:
- Who did it?
- When was it done?
- What was done?
- What were the results?
- Documents that SOPs and protocol were
followed
www.rogeralison.com
Data and Documentation
Raw Data:
- Original records (or verified copies) of
original observations and activities in the
study
- Recorded directly, promptly, accurately,
legibly and identified by who did it.
www.rogeralison.com
Data and Documentation
Raw Data:
- Original records (or verified copies) of
original observations and activities in the
study
- Recorded directly, promptly, accurately,
legibly and identified by who did it.
www.rogeralison.com
Histology Documentation
- Tissues taken
- Tissues trimmed
- Tissues in block
- Tissues on slide
- Staining procedures
- QC check done
www.rogeralison.com
Histology Quality
Pathologist’s niggles:
- Same blocking pattern every time, e.g.
ovaries/uterine horns/cervix/vagina
- No unnecessary extra sections
- No mixing slides of different thickness
- Same stain colour for control and treated
www.rogeralison.com
Histology Materials
Specimens (wet tissue, blocks, slides)
- Uniquely identified
- Retained
- Retrievable for future queries
www.rogeralison.com
Histology Quality Control
- Check that activities carried out properly
- Check all tissues taken at necropsy
- Check slide identification, sectioning,
staining
- Check tissue on slide
- Check data complete, signed
- Second person does it! Not QA!
www.rogeralison.com
Pathology Raw Data
- Record of the pathologist’s findings for
individual animals (when pathology data
finalised)
- Pathologist’s text interpreting the
findings
- (Possibly) computer file containing
study data
www.rogeralison.com
Pathology Quality Control
Peer Review:
- Review by a second pathologist of draft
report, 10% of animals, all neoplasms,
all target organs.
- Discussion of Peer Review findings
using double header microscope
- Final Report with consensus opinion
between pathologists
www.rogeralison.com
Pathology Quality Control
Peer Review:
- Typically takes two weeks for a
carcinogenicity study
- Data retained: records of animals and
organs examined, consensus achieved
- Not about “correcting” minor variations
between pathologists
- Best result as a collaborative exercise
www.rogeralison.com
Pathology Quality Control
Pathology Working Group (PWG):
- After report finalised, often mouse and
rat studies together
- Study pathologist, reviewing
pathologist, PWG leader, six “Experts”
- Characterise important or controversial
findings and assess their significance to
humans
www.rogeralison.com
Study Report
- Complete and accurate reflection of
protocol and raw data
- One study, one report
- Reviewed and approved by QA
- Signed by responsible people
- Date of report and finalisation is date
signed by study director
www.rogeralison.com
Archive
- All data and specimens retained after
study completion
- Secure, limited access
- Protected against deterioration
- Easily retrievable
- Regulations define period of retention,
but usually held for useful duration of
the compound
www.rogeralison.com
Computers
- Same principles of GLP apply
- Suitable for purpose
- Raw data defined
- Formal validation process of hardware
and software before operational use
- Maintenance, backup, disaster plan,
obsolescence and migration to new
system need to be defined
www.rogeralison.com
Multi-site Studies
Multi-site study
- Where phases are conducted on more
than one site
- Phase: a defined set of activities
- Test Facility: location of Study Director
- Test Sites: locations of other phases
- Principal Investigators: carry out duties
of study director at test sites
www.rogeralison.com
Multi-site Studies
Protocol
- Identify test sites, PI, and phases
- How test site data will be included in
report
SOPs
- Selection and monitoring of test site
- QA procedures
- Chain of custody for data and specimens
www.rogeralison.com
Multi-site Studies
Report
- One report for study
- Include PI contributions
- Include evidence of QA involvement
- Define archive location
- Indicate degree of GLP compliance
- Compliance statement for whole study
signed by Study Director
www.rogeralison.com
Multi-site Studies
Practical issues:
- Communication (Languages!)
- Defining responsibilities
- Assessment of test sites
- Monitoring and reporting of findings
- Chain of custody for samples and
specimens
www.rogeralison.com